Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:09 PM
Ignite Modification Date:
2025-12-24 @ 9:09 PM
NCT ID:
NCT00695604
Eligibility Criteria:
Inclusion criteria:
* Physician diagnosis of asthma.
* Age ≥18 years and ≤50 years
* Evidence of airflow obstruction as measured by spirometry and flow-volume loop per American Thoracic Society guidelines.
* Treatment for asthma with:
* daily inhaled corticosteroids and long-acting beta2-agonists, AND
* as-needed use of a short-acting beta2-agonist
Exclusion criteria:
* History of \>10 pack-year tobacco use
* Other pulmonary or cardiac diagnosis that is actively being treated
* History of adverse events or allergy to fluticasone
* Systemic corticosteroid therapy within 7 days of study visit
* Inability to obtain written informed consent
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
50 Years
Study:
NCT00695604
Study Brief:
Protocol Section:
NCT00695604